370 related articles for article (PubMed ID: 15289373)
1. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
[TBL] [Abstract][Full Text] [Related]
2. Letter regarding article by Okoshi et al, "neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of {beta}-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion".
Lemmens K; Segers VF; De Keulenaer GW
Circulation; 2005 Apr; 111(13):e175; author reply e175. PubMed ID: 15811863
[No Abstract] [Full Text] [Related]
3. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes.
Nagata K; Ye C; Jain M; Milstone DS; Liao R; Mortensen RM
Circ Res; 2000 Nov; 87(10):903-9. PubMed ID: 11073886
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of McN-A-343 on membrane current and contraction in guinea pig ventricular myocytes.
Shen JB; Jiang B; Pappano AJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):641-8. PubMed ID: 10411573
[TBL] [Abstract][Full Text] [Related]
5. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.
Danson EJ; Zhang YH; Sears CE; Edwards AR; Casadei B; Paterson DJ
Cardiovasc Res; 2005 Sep; 67(4):613-23. PubMed ID: 15936740
[TBL] [Abstract][Full Text] [Related]
6. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
Martin SR; Emanuel K; Sears CE; Zhang YH; Casadei B
Cardiovasc Res; 2006 Apr; 70(1):97-106. PubMed ID: 16545353
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
Vandecasteele G; Eschenhagen T; Scholz H; Stein B; Verde I; Fischmeister R
Nat Med; 1999 Mar; 5(3):331-4. PubMed ID: 10086391
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic modulation of the sodium-calcium exchanger in heart failure.
Wei SK; Ruknudin AM; Shou M; McCurley JM; Hanlon SU; Elgin E; Schulze DH; Haigney MC
Circulation; 2007 Mar; 115(10):1225-33. PubMed ID: 17339552
[TBL] [Abstract][Full Text] [Related]
10. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.
Champion HC; Georgakopoulos D; Takimoto E; Isoda T; Wang Y; Kass DA
Circ Res; 2004 Mar; 94(5):657-63. PubMed ID: 14752030
[TBL] [Abstract][Full Text] [Related]
11. Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes.
Ye C; Sowell MO; Vassilev PM; Milstone DS; Mortensen RM
J Mol Cell Cardiol; 1999 Sep; 31(9):1771-81. PubMed ID: 10471359
[TBL] [Abstract][Full Text] [Related]
12. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
[TBL] [Abstract][Full Text] [Related]
13. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
14. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node.
Cifelli C; Rose RA; Zhang H; Voigtlaender-Bolz J; Bolz SS; Backx PH; Heximer SP
Circ Res; 2008 Aug; 103(5):527-35. PubMed ID: 18658048
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
Devic E; Xiang Y; Gould D; Kobilka B
Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
[TBL] [Abstract][Full Text] [Related]
16. Sustained beta-adrenergic stimulation increased L-type Ca2+ channel expression in cultured quiescent ventricular myocytes.
Akuzawa-Tateyama M; Tateyama M; Ochi R
J Physiol Sci; 2006 Apr; 56(2):165-72. PubMed ID: 16839451
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
[TBL] [Abstract][Full Text] [Related]
18. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
19. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.
Wang W; Zhu W; Wang S; Yang D; Crow MT; Xiao RP; Cheng H
Circ Res; 2004 Oct; 95(8):798-806. PubMed ID: 15375008
[TBL] [Abstract][Full Text] [Related]
20. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
